“We over-estimate the impact of technology in the short-term and underestimate the effect in the long run.” - Amara's LawI am a healthcare change catalyst and evangelist who challenges the status quo while understanding the world in which healthcare providers and organizations function. I strongly believe that medicine and healthcare are being transformed, driven by Deep Tech, representing an unprecedented opportunity for better patient outcomes. I am the founder and CEO of Galen Growth, a pioneering global think tank advancing digital health innovation. With approximately a decade of unparalleled expertise, we have consistently delivered cutting-edge research, analytics, and insights to industry leaders and investors, solidifying our reputation as the premier authority in this dynamic field.With over 25 years of experience in healthcare with leading brands including Eli Lilly, Boston Scientific, Baxter, GSK, and Merck&Co., I have a deep understanding of organic and inorganic growth in healthcare in both developed and emerging markets. I gained extensive international business experience across Europe, the Middle East and Asia.In 2012, I founded The Propell Group, a successful boutique venture investor based in Singapore. The Propell Group focuses on promising HealthTech startups and growth companies. I also co-founded the Global Cancer Research & Commercialisation Fund in 2016 to establish greater collaboration and open innovation between research institutes, research foundations, and investors worldwide. The fund aimed to harness technology and business model innovation to deliver superior financial returns and, most importantly, drive better outcomes for cancer patients. Living in the Age of the Jerk is my latest book, which focuses on the impact of the Fourth and Fifth Industrial Revolutions' significant technological changes on humans, our environment, and our society. Will this Techopia lead to utopia or dystopia?I am also a regular host and speaker on HealthTech / Digital Health Innovation and Disruption.